Recent Work
-
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
For every 10% reduction in expected U.S. revenues, pharmaceutical innovation is expected to decline by up to 15%, finds a new Schaeffer Center analysis. Policymakers should consider whether lowering drug prices risks undermining long-term population health.
Categorized in -
Medicare Beneficiaries Face Much Higher Drug Costs as Plans Quickly Shift to Coinsurance
The share of stand-alone prescription drug plans using coinsurance for preferred brand name drugs surged in recent years, exposing more patients to list prices that are often artificially inflated.
Categorized in -
Seminar Series – Amitabh Chandra
Amitabh Chandra is the Henry and Allison McCance Family Professor of Business Administration at Harvard Business School where he is the Faculty Chair of the MS/MBA program in the life-sciences.
-
Medicare Enrollment Linked to Sharp Decline in Use of Mental Healthcare Services
People with substantial mental health needs appear to receive much less mental healthcare after they age into Medicare, while use of non-mental healthcare is unaffected.
Categorized in -
Nearly 1 in 3 Retail Pharmacies Have Closed Since 2010, Widening Health Disparities
The risk of closure was higher in predominantly Black and Latino neighborhoods, and independent pharmacies were more than twice as likely to face closure.
Categorized in